MAR 11, 2015 2:42 PM PDT

Understanding of Cancer Cell Enzyme Flipped on its Head

WRITTEN BY: Ilene Schneider
Researchers from Manchester, working with scientists in California, have found that certain molecules long thought to promote cancer growth, in fact suppress tumors, suggesting that therapeutic approaches should aim to restore, rather than block, their activity.

The protein kinase C (PKC) family of molecules are enzymes that facilitate a range of cellular processes, including cell survival, proliferation, migration and death. In the 1980s it was found that PKCs were activated by cancer-causing phorbol esters, and led to the conclusion that PKCs themselves induced the development of tumors.

However, attempts to develop new treatments that prevent tumor cell growth by blocking the activity of PKCs have had little success. A recent study involving Manchester scientists, the findings of which have been published in the journal Cell, has explored the effect of mutations in PKC on tumor growth.

Dr John Brognard, from the Cancer Research UK Manchester Institute at The University of Manchester - part of the Manchester Cancer Research Centre - said: "Despite phorbol esters being known to cause cancers, we've seen frustratingly little progress when targeting PKCs to stop tumor growth."

The Manchester group collaborated with a team from the University of California, San Diego, to analyse PKC mutations in human cancer cells. They found that most were ‘loss of function' mutations, meaning that the genetic changes stopped PKC from working.

When they corrected these mutations in bowel cancer cells, they saw a reduction in tumor growth, meaning that contrary to our previous understanding, PKC normally acts to block cancer.

"Clinical trials have so far been working on the incorrect assumption that PKC enzymes cause cancer growth. This new insight from our studies has turned current thinking on its head. Looking ahead, instead of blocking PKC activity, new therapies should instead be targeting mechanisms to restore its activity," added Dr Brognard.

Source: University of Manchester
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 09, 2020
Cancer
Microbubbles enhance delivery of chemotherapy drug
SEP 09, 2020
Microbubbles enhance delivery of chemotherapy drug
New research published in APL Bioengineering reports on a new technology developed by scientists at Tulane Universi ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
Loading Comments...